Literature DB >> 8646545

The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.

F R Appelbaum1.   

Abstract

Since its first successful application 25 years ago, the clinical use of bone marrow and peripheral blood stem cell transplantation has increased dramatically. Transplantation allows for the administration of high doses of systematic chemotherapy and radiotherapy and confers an antitumor effect separate from the effects of chemotherapy. However,complications including toxicity of treatment, graft failure, and graft-versus-host disease exist. This article reviews the history and current use of bone marrow and peripheral blood stem cell transplantation and outlines new approaches for clinical application.

Entities:  

Mesh:

Year:  1996        PMID: 8646545     DOI: 10.3322/canjclin.46.3.142

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  11 in total

1.  Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer.

Authors:  H Gilbert Welch; Juliana Mogielnicki
Journal:  BMJ       Date:  2002-05-04

2.  Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation.

Authors:  Jada G Hamilton; Lisa M Wu; Jane E Austin; Heiddis Valdimarsdottir; Katie Basmajian; Annamarie Vu; Scott D Rowley; Luis Isola; William H Redd; Christine Rini
Journal:  Psychooncology       Date:  2012-05-18       Impact factor: 3.894

Review 3.  The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.

Authors:  Kui-Wu Yao; Liang-Deng Zhang; Jie Wang
Journal:  Chin J Integr Med       Date:  2011-08-01       Impact factor: 1.978

4.  Prospective study of dental intervention for hematopoietic malignancy.

Authors:  K Tsuji; Y Shibuya; M Akashi; S Furudoi; K Yakushijin; S Kawamoto; A Okamura; H Matsuoka; T Komori
Journal:  J Dent Res       Date:  2014-12-10       Impact factor: 6.116

Review 5.  Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.

Authors:  Irina A Tikhonova; Martin W Hoyle; Tristan M Snowsill; Chris Cooper; Joanna L Varley-Campbell; Claudius E Rudin; Ruben E Mujica Mota
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

Review 6.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

7.  Iron overload in patients undergoing hematopoietic stem cell transplantation.

Authors:  Vinod Pullarkat
Journal:  Adv Hematol       Date:  2010-09-08

8.  Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic.

Authors:  Ruth Chieng; John Coutsouvelis; Susan Poole; Michael J Dooley; Diana Booth; Andrew Wei
Journal:  Support Care Cancer       Date:  2013-08-21       Impact factor: 3.603

9.  Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.

Authors:  Fausto R Loberiza; Stephanie J Lee; John P Klein; Anna Hassebroek; Jason G Dehn; Haydar A Frangoul; Theresa Hahn; Gregory Hale; Hillard M Lazarus; Charles F LeMaistre; Richard T Maziarz; J Douglas Rizzo; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-30       Impact factor: 5.742

10.  Psychosocial factors predicting survival after allogeneic stem cell transplant.

Authors:  Brindha Pillay; Stuart J Lee; Lynda Katona; Sue Burney; Sharon Avery
Journal:  Support Care Cancer       Date:  2014-04-16       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.